Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoFactor and 5-FU in Advanced Breast Cancer
NCT00434369Phase 2Unknown
- Sponsor
- Mast Therapeutics, Inc.
- Start
- Feb 2006
- Countries
- 5
01
Overview
A Phase 2 trial of folitixorin in breast cancer, sponsored by Mast Therapeutics, Inc.. Status: unknown.
02
Drugs
folitixorin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00434369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434369.